Earlier this month (July 2022), the U.S. Food and Drug Administration (FDA) warned that the puberty blockers known as gonadotropin-releasing hormone (GnRH) agonists could lead to the development of pseudotumor cerebri,…Continue reading‘Our Bodies Were Not Made For These Drugs’: FDA Issues Warning on Puberty Blockers